These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 9253238)

  • 1. Experimental study on estimating the immunogenic potency of diphtheria and/or tetanus toxoids in monovaccines and associated vaccines.
    Durbacă S; Andronescu C; Diaconescu A
    Roum Arch Microbiol Immunol; 1996; 55(2):119-31. PubMed ID: 9253238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negatively charged liposomes as immunological adjuvant for tetanus and diphtheria toxoids.
    Popescu C; Durbaca S; Ivanov D
    Roum Arch Microbiol Immunol; 1998; 57(3-4):255-61. PubMed ID: 11845437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development studies of lyophilized standard diphtheria-tetanus-pertussis vaccines].
    Ozcengiz E; Unver D; Cayan HH; Atakan Ablay P; Kanik E
    Mikrobiyol Bul; 2007 Apr; 41(2):165-73. PubMed ID: 17682702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition of minimum standards for immunogenicity--potential problems of serological correlates--possible interference. Serological correlates for diphtheria-tetanus-whole cell pertussis vaccines.
    Heron I
    Biologicals; 1994 Dec; 22(4):389-90. PubMed ID: 7779366
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibody response to the fractionated administration of the 2d or 3d basic vaccination injection with a mixed vaccine against diphtheria, tetanus and pertussis].
    Vodicková M; Svandová E
    Cesk Pediatr; 1986 Jun; 41(6):321-3. PubMed ID: 2872973
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of diphtheria and tetanus vaccination in Gaza, Palestine.
    Al Aswad IH; Shubair ME
    East Mediterr Health J; 2009; 15(2):285-94. PubMed ID: 19554974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The antidiphtheria and antitetanus immunities of children of the Maritime Territory after the use of adsorbed DTP vaccine and adsorbed DT-m anatoxin].
    Zaporzhets TS; Lunika IG; Greben'kova LK; Belogolovkina NA; Makarenkova ID; Besednova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):57-9. PubMed ID: 10356739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The determination of the protective potency of the diphtheria component in combined vaccines by the indirect hemagglutination (IHA) method].
    Unver SD; Ozcengiz E
    Mikrobiyol Bul; 1990 Oct; 24(4):327-35. PubMed ID: 2287290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
    Winsnes R; Sesardic D; Daas A; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The level of postvaccinal immunity to diphtheria, tetanus and poliomyelitis in relation to the number of inoculations].
    Chudnaia LM; Oksiiuk VG; Shekhter AB; Krasiuk LS; Afanas'eva SM; Bryzhata SI; Kozhan NE; Chaban EP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):46-9. PubMed ID: 1650072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvants for Clostridium tetani and Clostridium diphtheriae vaccines updating.
    Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; Redwan EM
    Hum Antibodies; 2017; 25(1-2):23-29. PubMed ID: 27858706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative evaluation of the immunological efficacy of ADPT vaccine and ADT-M anatoxin in the immunization of children against diphtheria and tetanus].
    Rusakova EV; Bezuglova MS; Vasil'eva VI; Frank KD; Panina GM
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):52-5. PubMed ID: 1950266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of tetanus and diphtheria antitoxins in mouse sera by indirect haemagglutination.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Mar; 30(1):23-8. PubMed ID: 9842161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
    Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
    Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vivo and in vitro methods for determining unitage of diphtheria antitoxin in adsorbed diphtheria-tetanus (DT) and diphtheria-tetanus-pertussis (DTP) vaccines.
    Shinde YP; Jadhav SS
    Dev Biol Stand; 1996; 86():245-60. PubMed ID: 8785954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
    Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
    Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.